IMAC Holdings, Inc. (IMAC): Price and Financial Metrics


IMAC Holdings, Inc. (IMAC): $1.03

-0.02 (-1.90%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

IMAC Stock Summary

  • IMAC has a market capitalization of $26,732,330 -- more than approximately only 4.98% of US stocks.
  • IMAC's went public 3.13 years ago, making it older than merely 9.92% of listed US stocks we're tracking.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for IMAC comes in at -69.11% -- higher than that of only 6.09% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to IMAC Holdings Inc, a group of peers worth examining would be EVH, HLIO, HMTV, MEG, and MNSB.
  • IMAC's SEC filings can be seen here. And to visit IMAC Holdings Inc's official web site, go to www.imacregeneration.com.

IMAC Valuation Summary

  • IMAC's price/sales ratio is 2.9; this is 74.45% lower than that of the median Healthcare stock.
  • IMAC's EV/EBIT ratio has moved up 3.4 over the prior 31 months.
  • IMAC's price/earnings ratio has moved up 1.1 over the prior 31 months.

Below are key valuation metrics over time for IMAC.

Stock Date P/S P/B P/E EV/EBIT
IMAC 2021-08-31 2.9 1.5 -7.6 -7.4
IMAC 2021-08-30 2.8 1.5 -7.3 -7.0
IMAC 2021-08-27 2.8 1.5 -7.2 -6.9
IMAC 2021-08-26 2.8 1.5 -7.2 -6.9
IMAC 2021-08-25 2.7 1.4 -7.0 -6.8
IMAC 2021-08-24 2.8 1.4 -7.1 -6.9

IMAC Price Target

For more insight on analysts targets of IMAC, see our IMAC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $3.63 Average Broker Recommendation 1.75 (Moderate Buy)

IMAC Stock Price Chart Interactive Chart >

Price chart for IMAC

IMAC Price/Volume Stats

Current price $1.03 52-week high $2.75
Prev. close $1.05 52-week low $0.75
Day low $1.03 Volume 1,843
Day high $1.03 Avg. volume 916,234
50-day MA $0.92 Dividend yield N/A
200-day MA $1.20 Market Cap 27.28M

IMAC Holdings, Inc. (IMAC) Company Bio


IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. Its services include medical treatments, regenerative medicine, physical medicine, physical therapy, spinal decompression and chiropractic manipulation. The company was founded by Matthew C. Wallis, Jason William Brame and Jeffrey S. Ervin in August 2000 and is headquartered in Brentwood, TN.


IMAC Latest News Stream


Event/Time News Detail
Loading, please wait...

IMAC Latest Social Stream


Loading social stream, please wait...

View Full IMAC Social Stream

Latest IMAC News From Around the Web

Below are the latest news stories about IMAC Holdings Inc that investors may wish to consider to help them evaluate IMAC as an investment opportunity.

IMAC Holdings, Inc. Announces Completion of Second Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease

BRENTWOOD, Tenn., Feb. 16, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), today announces it has completed the second cohort of its Phase 1 clinical trial for its investigational compound utilizing umbilical cord-derived allogenic mesenchymal stem cells for the treatment of bradykinesia due to Parkinson’s disease. The second cohort consists of five patients with bradykinesia due to Parkinson’s disease receiving an intravenous infusion of a medium concentra

Yahoo | February 16, 2022

Ben Lerner to join IMAC as COO

IMAC Holdings <> has appointed healthcare veteran Ben Lerner as Chief Operating Officer ((COO)).Matt Wallis, a founder of IMAC and current COO, will continue as President…

Seeking Alpha | February 9, 2022

IMAC Holdings, Inc., Announces Dr. Ben Lerner as Chief Operating Officer

Dr. Lerner, a New York Times best-selling author and holistic health and business expert, brings healthcare growth experience to IMAC executive team. BRENTWOOD, Tenn., Feb. 09, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative and rehabilitative orthopedic treatments without the use of surgery or opioids, announces the addition of healthcare veteran Dr. Ben Lerner to the posit

Yahoo | February 9, 2022

IMAC Holdings, Inc. Enters 2022 with Improved Balance Sheet

Company reduces significant debt in 2021 BRENTWOOD, Tenn., Jan. 19, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, has announced the repayment of three loans representing more than 95% of its debt in accordance with scheduled debt service over the past 10 months. “We worked diligently to reduce our

Yahoo | January 19, 2022

IMAC Holdings to launch BACK.co app to provide mobile queue registration

IMAC Holdings (IMAC) to launch BACK.co app for the The Back Space pilot program to provide mobile queue registration and serves to helping consumers develop a personalized, affordable

Seeking Alpha | January 13, 2022

Read More 'IMAC' Stories Here

IMAC Price Returns

1-mo 31.65%
3-mo -2.83%
6-mo -21.37%
1-year -44.32%
3-year -74.57%
5-year N/A
YTD -9.65%
2021 -25.49%
2020 2.00%
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8729 seconds.